These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 13688200)

  • 21. Lactic dehydrogenase versus glutamic oxalacetic acid transaminase as a diagnostic test for myocardial infarction.
    FREEMAN I; JACKSON DA; COLLIER CS
    Am J Med Sci; 1959 Jun; 237(6):768-70. PubMed ID: 13661165
    [No Abstract]   [Full Text] [Related]  

  • 22. Serum transaminase as an aid in diagnosis of acute myocardial infarction.
    GROOM D; DOUGLAS L; HERBERT EG; MCCORD WM
    J S C Med Assoc; 1957 Apr; 53(4):119-23. PubMed ID: 13417222
    [No Abstract]   [Full Text] [Related]  

  • 23. Serum transaminase determinations as a diagnostic aid in myocardial infarction.
    SHABETAI R; IGLAUER A; ANDERSON DM
    Br Med J; 1957 Mar; 1(5018):555-7. PubMed ID: 13404232
    [No Abstract]   [Full Text] [Related]  

  • 24. Glutamic-oxalacetic transaminase in the diagnosis of myocardial infarction. I. Serum transaminase activity in relation to the clinical picture.
    BIORCK G; HANSON A
    Acta Med Scand; 1956 Oct; 155(4):317-24. PubMed ID: 13361845
    [No Abstract]   [Full Text] [Related]  

  • 25. Serum glutamic oxaloacetic transaminase activity and serum glutamic pyruvic transaminase activity in liver diseases.
    VANIKAR VA; BHATT JT
    Indian J Med Sci; 1960 Apr; 14():344-50. PubMed ID: 13841248
    [No Abstract]   [Full Text] [Related]  

  • 26. TRANSAMINASE in myocardial infarction.
    Br Med J; 1957 Mar; 1(5018):573. PubMed ID: 13404241
    [No Abstract]   [Full Text] [Related]  

  • 27. The diagnostic, prognostic and epidemiologic significance of serum glutamic oxaloacetic transaminase (SGO-T) alterations in acute hepatitis.
    JERVIS G; LADUE JS; WROBLEWSKI F
    Ann Intern Med; 1956 Nov; 45(5):782-800. PubMed ID: 13373187
    [No Abstract]   [Full Text] [Related]  

  • 28. Daily changes in serum glutamic oxalacetic acid transaminase, with reference to the clinical aspects.
    TOIVANEN P; HARRI J; KALLIOMAKI JL
    Cardiologia (Basel); 1963; 42():391-4. PubMed ID: 13985298
    [No Abstract]   [Full Text] [Related]  

  • 29. Use of serum transaminase levels in the differentiation of pulmonary embolism and myocardial infarction.
    GOLDSTEIN F; ISRAEL HL; SELIGSON D
    N Engl J Med; 1956 Apr; 254(16):746-9. PubMed ID: 13309669
    [No Abstract]   [Full Text] [Related]  

  • 30. The serum glutamic oxalacetic transaminase determination: its clinical use in the diagnosis of myocardial infarction and in the differential diagnosis of chest pains.
    SELIGSON D; ZINGESSER LH; GOLDSTEIN F
    Pa Med J; 1957 Jun; 60(6):728-34. PubMed ID: 13431381
    [No Abstract]   [Full Text] [Related]  

  • 31. Variations in serum glutamic oxaloacetic transaminase activity in experimental and clinical coronary insufficiency, pericarditis, and pulmonary infarction.
    NYDICK I; RUEGSEGGER P; WROBLEWSKI F; LADUE JS
    Circulation; 1957 Mar; 15(3):324-34. PubMed ID: 13404705
    [No Abstract]   [Full Text] [Related]  

  • 32. Serum glutamic oxalacetic transaminase in acute myocardial infarction.
    DEWAR HA; ROWELL NR; SMITH AJ
    Br Med J; 1958 Nov; 2(5105):1121-5. PubMed ID: 13584872
    [No Abstract]   [Full Text] [Related]  

  • 33. Serum glucose-6-phosphate dehydrogenase in the diagnosis of myocardial infarction. Comparison of its clinical value with that of glutamic-oxalacetic transaminase.
    KERPPOLA W; NIKKILA EA; PITKANEN E
    Acta Med Scand; 1960 Jan; 166():17-24. PubMed ID: 14408628
    [No Abstract]   [Full Text] [Related]  

  • 34. [Significance of the determination of glutamic-oxalic transaminase in the diagnosis and differential diagnosis of acute myocardial infarction].
    BAGROV IaIu
    Sov Med; 1961 Oct; 25():3-11. PubMed ID: 13863946
    [No Abstract]   [Full Text] [Related]  

  • 35. [Serum glutamic oxaloacetic transaminase in myocardial infarct & liver diseases: general review].
    BELANGER M; LESSARD A
    Laval Med; 1958 Jun; 26(1):74-110. PubMed ID: 13564853
    [No Abstract]   [Full Text] [Related]  

  • 36. Experience with serum glutamic oxaloacetic transaminase.
    BERKMAN F; BHARGAVA AN
    Can Med Assoc J; 1959 Jun; 80(11):861-5. PubMed ID: 13662936
    [No Abstract]   [Full Text] [Related]  

  • 37. [On increase of glutamic-oxalic transaminase (SGPT) activity in myocardial infarction].
    RAFALOWICZ A
    Pol Tyg Lek; 1961 Oct; 16():1529-31. PubMed ID: 14489823
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical observation on transaminase activity. II. Transaminase in myocardial infarction and angina pectoris.
    CHEN JS; TSAI HC; WU TL
    Taiwan Yi Xue Hui Za Zhi; 1962 Aug; 61():707-13. PubMed ID: 14020506
    [No Abstract]   [Full Text] [Related]  

  • 39. Colorimetric measurement of serum glutamic oxaloacetic transaminase.
    CABAUD P; LEEPER R; WROBLEWSKI F
    Am J Clin Pathol; 1956 Sep; 26(9):1101-5. PubMed ID: 13362163
    [No Abstract]   [Full Text] [Related]  

  • 40. [The prognostic significance of high SGOT titer in myocardial infarct].
    MASSON NG; VERHEUGT AP
    Ned Tijdschr Geneeskd; 1962 Apr; 106():858-61. PubMed ID: 14470955
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.